Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

American and Frenchman Turning Pro with Team Novo Nordisk

Team Novo Nordisk, the world's first all-diabetes professional cycling team, brings up two of its best development riders, American Logan Phippen and Frenchman Lucas Dauge, onto the men's pro squad for the 2021 season.


News provided by

Team Novo Nordisk

Nov 11, 2020, 08:15 ET

Share this article

Share toX

Share this article

Share toX

Logan Phippen was diagnosed with type 1 diabetes in 2016 over the weekend of his 24th birthday.
Logan Phippen was diagnosed with type 1 diabetes in 2016 over the weekend of his 24th birthday.

ATLANTA, Nov. 11, 2020 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all-diabetes professional cycling team, brings up two of its best development riders, American Logan Phippen and Frenchman Lucas Dauge, onto the men's pro squad for the 2021 season. Phippen serves as the USA-registered team's first American on the men's professional roster since 2018.

"Moving up to the pro ranks always means a new level of responsibility both as an athlete and as an ambassador to the diabetes community. I love getting to see Logan and Lucas's dreams come true," said Team Novo Nordisk CEO and co-founder Phil Southerland. "Through our extensive development pipeline, many of our athletes have a shared journey up to the pro ranks. When a devo rider advances to the pro team, it is a reunion with their past teammates. They help one another with the adjustments while serving as a reminder of the hard work and dedication it takes to reach the pro team."

“Moving up to the pro ranks always means a new level of responsibility both as an athlete and as an ambassador to the diabetes community. I love getting to see Logan and Lucas’s dreams come true," said Team Novo Nordisk CEO and co-founder Phil Southerland.

Post this

To become a member of Team Novo Nordisk, all athletes must have type 1 diabetes. Since its launch in December 2012, the organization has focused heavily on identifying and developing endurance athletes worldwide with diabetes. Dauge and Phippen are two in a long line of riders advancing through the team's development pipeline. The team's multi-tiered structure dedicates time and resources to allow riders to develop and help ensure a successful transition into the professional ranks.

Phippen was diagnosed with type 1 diabetes in 2016 over the weekend of his 24th birthday. The diagnosis never disheartened the Portland-native as he knew it was a condition that he could manage. With the help from his medical team, he was back on the bike within a week following his diagnosis. Because he had already seen Team Novo Nordisk in the peloton, he immediately reached out to the team to see if they had a spot for him on their elite team. Instead, Team Novo Nordisk offered him a chance to race for the development squad, and Phippen instantly jumped at the chance.

"My appreciation for this opportunity is immense and I am overflowing with gratitude to the team's management for believing in me. I recognize this is a large step forward and I am motivated to continue distilling and refining my development process as I move into this new chapter," said Phippen. "Pulling on the pro men's jersey is quite special. Since I was a young child, racing at the pro level was my dream. My life has taken many courses and I'm so proud to pull on the Team Novo Nordisk Changing Diabetes jersey as we head into the 100th year anniversary since the discovery of insulin, meaning life for those of us living with diabetes."

Dauge is set to become the third Frenchman amongst the Team Novo Nordisk ranks joining Mehdi Benhamouda and Charles Planet. The Hautes-Alpes-native was diagnosed with type 1 diabetes when he was 18 years old. He was a promising skier in his youth but fell in love with cycling after learning about Team Novo Nordisk. In 2017, he applied for Talent ID camp and began his journey through the team's development pipeline.

"It's a dream come true becoming a professional cyclist. I worked hard during the suspension of racing due to Covid-19 and managed to progress this season even without much racing," explained Dauge. "When I joined the development team three years ago, I didn't overthink about becoming a pro, but year after year, I saw with hard work that it could be possible, and it eventually became a goal that I believed in."

The fight and desire Dauge has shown over the past years was a key factor for management when deciding to take him to the next step.

"It is with great pleasure to welcome Lucas to the professional team. He is a true fighter and worked extremely hard for this advancement," said General Manager Vassili Davidenko. "Lucas's story is very inspiring as a former skier who fell in love with cycling. He learned about the Team Novo Nordisk program via social media, attended Talent ID camp, and has become very dedicated to the sport. Within three seasons on our development team, he made significant progress, shown good results, and deserves his spot on the professional team for the 2021 season."

Team Novo Nordisk ended its 2020 racing season at Paris-Tours. The team recently came together in Rhodes, Greece for a 2021 training camp before heading into the off-season.

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

# # #
Media Contact:
Fitzalan Crowe for Team Novo Nordisk
[email protected]
+1-703-596-2020

Media Contact

Fitzalan Crowe, Team Novo Nordisk, 703-592-2020, [email protected]

SOURCE Team Novo Nordisk

Related Links

http://www.teamnovonordisk.com

Modal title

Lucas Dauge was diagnosed with type 1 diabetes when he was 18 years old.
Lucas Dauge was diagnosed with type 1 diabetes when he was 18 years old.
Lucas Dauge was diagnosed with type 1 diabetes when he was 18 years old.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.